Related Experiment Video

Updated: Jun 17, 2026

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Platelet-derived microparticle levels are significantly elevated in patients treated by elective stenting compared to

Béla Nagy1, Tibor Szuk, Ildikó Beke Debreceni

  • 1Department of Clinical Biochemistry and Molecular Pathology, University of Debrecen, Hungary.

Platelets
|January 7, 2010
PubMed

Insights

Percutaneous coronary intervention significantly increases platelet activation markers, including platelet microparticles (PMPs), shortly after stenting. These early cellular changes indicate heightened platelet reactivity following stent implantation in coronary artery disease patients.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Biomarker Discovery

Background:

  • Percutaneous coronary intervention (PCI) procedures like stenting can cause endothelial damage and significant platelet activation.
  • Activated platelets contribute to prothrombotic states and may lead to subacute stent thrombosis.
  • Platelet microparticles (PMPs) are released upon platelet activation and can serve as indicators of thrombotic events.

Purpose of the Study:

  • To investigate the levels of PMPs and other platelet activation markers at an early time point after bare metal stent implantation.
  • To compare these markers in patients undergoing stenting with aspirin pre-treatment versus those undergoing diagnostic catheterization alone.
  • To identify early cellular changes indicative of stent implantation's platelet-activating effects.

Main Methods:

  • Measurement of PMPs, P-selectin expression on platelets, and platelet-monocyte heterotypic aggregates.
  • Comparison of marker levels 15 minutes post-stenting in PCI patients versus control subjects.
  • Analysis of soluble P-selectin levels.

Main Results:

  • Platelet microparticle levels were significantly elevated 15 minutes after stenting (557 +/- 83/microl vs. 325 +/- 42/microl, p < 0.05).
  • Platelet P-selectin expression and platelet-monocyte heterotypic aggregates were also significantly higher in stented patients.
  • No significant difference was observed in soluble P-selectin levels between the groups.

Conclusions:

  • Stent implantation triggers significant early platelet activation, evidenced by increased PMPs, P-selectin expression, and platelet-monocyte aggregates.
  • These cellular changes are sensitive markers for detecting the immediate platelet-activating effects of stent implantation.
  • The findings highlight the prothrombotic potential induced by PCI and support monitoring these markers post-procedure.

More Related Videos

Routine Screening Method for Microparticles in Platelet Transfusions09:49

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...